Delgocitinib
Leo Pharma
['delgocitinib']
new phase 3 data: delgocitinib achieves significant chronic hand eczema improvement at 16 weeks. #aad2023 #aad23 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.